Torl BioTherapeutics' $158 million Series B-2 financing will finance clinical testing of its pipeline of antibody drug conjugates in development for various types of cancer. Neuroscience and immunology are among the therapeutic areas represented in our roundup of other recent biotech financings.
Join us this Tuesday at 1p ET as Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
CMS released a proposed rule this week that would boost hospitals' inpatient payment rates by 2.6%. Hospitals groups have swiftly denounced this plan, arguing that this payment update is insufficient and will jeopardize hospitals' financial stability.
Kaiser Permanente's new Food is Medicine Center of Excellence will "combine clinical services, research, education and community engagement," according to the organization.
In this month's episode, Senior Reporter Katie Adams discussed some executive hires, promotions and departures that recently occurred in the healthcare world, as well as layoffs affecting the industry. We also hear from Brian Anderson, who recently became CEO of the Coalition for Health AI (CHAI).
No comments